USPTO serial 90550735
LEA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- IN, SUNG HYUN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LEA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KHANH T. GLATZEL
KHANH T. GLATZEL PREMIUM IP SERVICES, P.C.1637 E. VALLEY PKWY #182ESCONDIDO, CA 92027UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for industrial purposes; Chemicals for use in biotechnological product development; Chemicals for use in industry; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the manufacture of cosmetic and dermatological products; Chemicals used in industry | ACTIVE | — |
| 003 | Chemicals sold as components of cosmetics | ACTIVE | — |
| 005 | Chemical preparations for pharmaceutical or medical purposes, namely, for eczema, psoriasis, sun burn, radiation dermatitis, atopic dermatitis and other dermatological disorders; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents for epidermis; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment and prevention of eczema, psoriasis, sun burn, radiation dermatitis, atopic dermatitis and other dermatological disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of eczema, psoriasis, sun burn, radiation dermatitis, atopic dermatitis and other dermatological disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for eczema, psoriasis, sun burn, radiation dermatitis, atopic dermatitis and other dermatological disorders; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neuropathix, Inc.
- Other trademarks owned by Neuropathix, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named LEA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 17, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 17, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 28, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 27, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 27, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 15, 2023 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Mar 14, 2023 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Mar 14, 2023 | PETG | PETITION TO REVIVE-GRANTED | — |
| Mar 14, 2023 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 17, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 16, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 14, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 14, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 4, 2022 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| May 4, 2022 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| May 4, 2022 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Feb 23, 2022 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Nov 25, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 26, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 26, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 28, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 3, 2021 | NWAP | NEW APPLICATION ENTERED | — |